DIMETHYLFUMARAT Spirig HC caps 240 mg 168 pce

7680691670039 CH-69167 L04AX07 01.99.0.

Active substances:

No images available

Details

Product number
6916702
CPT
-
Packaging group
168
Unit
Kapsel(n)
Composition
dimethylis fumaras 240 mg, cellulosum microcristallinum, povidonum K 30, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, E 171, triethylis citras, Kapselhülle: gelatina, E 171, E 172 (flavum), E 133, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula.

Articles (1)

Dimethylfumarat Spirig HC 240 mg, magensaftresistente Hartkapseln
Magensaftresistente Hartkapseln
168
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/02/2026
Patient information leaflet
Français
21/02/2026
Patient information leaflet
Italien
21/02/2026
Professional SmPC
Allemand
21/02/2026
Professional SmPC
Français
21/02/2026
Professional SmPC
Italien
21/02/2026

Detailed composition

Substance Quantity Type Category
dimethylis fumaras
240.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
crospovidonum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
triacetinum
- Substance HNIDK
talcum
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
E 171
- Substance FNIDK
triethylis citras
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 133
- Substance FIMDK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammoniae solutio concentrata
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 1038.40
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2026

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69167
Drug name
Dimethylfumarat Spirig HC, magensaftresistente Hartkapseln
Galenic form
KAHAM
ATC Code
L04AX07
Authorization status
Z
Dispensation category
B
First authorization
08/08/2024
Authorization expiration date
07/08/2029
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose-Therapeutika (Immunsuppressiva)

Packaging details

Description (FR)
DIMETHYLFUMARAT Spirig HC caps 240 mg 168 pce
Description (DE)
DIMETHYLFUMARAT Spirig HC Kaps 240 mg 168 Stk
Market launch
16/03/2026
Narcotic (BTM)
No

Original drug

Tecfidera, magensaftresistente Hartkapseln
CHF 287.50
View original

Other packaging sizes

DIMETHYLFUMARAT Spirig HC caps 120 mg 14 pce
14 KAP
View
DIMETHYLFUMARAT Spirig HC caps 240 mg 56 pce
56 KAP
View
Buy us a coffee Explore the data